Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 29;10(10):CD015022.
doi: 10.1002/14651858.CD015022.pub2.

Prevention of infection in peripheral arterial reconstruction of the lower limb

Rebeca M Correia  1 , Luis Cu Nakano  1   2 , Vladimir Vasconcelos  1   2 , Mateus Ab Cristino  1 , Ronald Lg Flumignan  1   2
Affiliations
Review

Prevention of infection in peripheral arterial reconstruction of the lower limb

Rebeca M Correia et al. Cochrane Database Syst Rev. .

Abstract

Background: Peripheral arterial disease (PAD) results from the narrowing of arteries. Arterial reconstruction surgery is the treatment of choice for severe cases. Graft infections and surgical site infections (SSIs) are a feared and common complication of vascular surgery. These infections have a significant global healthcare impact. Evaluating the effectiveness of preventive measures is essential.

Objectives: To assess the effects of pharmacological and non-pharmacological interventions, including antimicrobial therapy, antisepsis, and wound management, to prevent infection in patients undergoing any open or hybrid lower limb peripheral arterial reconstruction.

Search methods: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, LILACS, and CINAHL databases, as well as the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov up to 26 August 2024.

Selection criteria: We included all randomised controlled trials (RCTs) with a parallel (e.g. cluster or individual) design and quasi-RCTs that assessed any intervention to reduce or prevent infection following peripheral arterial reconstruction of the lower limb. There were no limitations on age and gender.

Data collection and analysis: We used standard Cochrane methodological procedures. Two review authors independently extracted the data and assessed the risk of bias in the included studies. We assessed the certainty of evidence using the GRADE approach.

Main results: We included 35 RCTs and five quasi-RCTs with a total of 7970 participants. We analysed 16 comparisons for nine outcomes. The four main comparisons were prophylactic antibiotics versus placebo or no treatment; short- (≤ 24 hours) versus long-duration prophylactic antibiotics (> 24 hours); different types of systemic antibiotic prophylaxis (one versus another); and closed incision negative pressure therapy versus standard wound closure. The primary outcomes were graft infection rate and SSI rate. The secondary outcomes were all-cause mortality, arterial reconstruction failure rate, re-intervention rate, amputation rate, pain resulting from the interventions to prevent infection, health-related quality of life, and adverse events resulting from the interventions to prevent infection. Not all outcomes were assessed across the different comparisons. Prophylactic antibiotics versus placebo (eight studies) Low-certainty evidence from eight included studies suggests that antibiotic prophylaxis may reduce the graft infection rate (risk ratio (RR) 0.19, 95% confidence interval (CI) 0.06 to 0.63; 6 studies, 979 participants; low-certainty evidence; number needed to treat (NNT) 5) and SSI rate (RR 0.20, 95% CI 0.11 to 0.34; 8 studies, 1188 participants; low-certainty evidence, NNT 9). There was no difference between the groups in the other outcomes that we could assess. Short-duration (≤ 24 hours) versus long-duration prophylactic antibiotics (> 24 hours) (three studies) Very low-certainty evidence from three included studies suggests that there is little or no significant difference in the graft infection rate (RR 1.40, 95% CI 0.09 to 20.65; 2 studies, 139 participants; very low-certainty evidence) or the SSI rate (RR 0.75, 95% CI 0.40 to 1.40; 3 studies, 247 participants; very low-certainty evidence) between short- and long-duration antibiotic prophylaxis. Different types of systemic antibiotic prophylaxis (one versus another) (seven studies) We divided seven studies comparing one antibiotic to another into four subgroups that compared different classes of antibiotics amongst themselves for short and long-term time points. We found little or no difference between the groups analysed. For graft infection rate, only the second- or third-generation cephalosporins versus first-generation cephalosporins comparison had quantitative data (RR 1.71, 95% CI 0.35 to 8.45; 4 studies, 1512 participants; very low-certainty evidence). For SSI rate, we could assess the following comparisons: second- or third-generation cephalosporins versus first-generation cephalosporins (RR 0.71, 95% CI 0.26 to 1.97; 4 studies, 956 participants; very low-certainty evidence); ciprofloxacin versus cefuroxime (RR 1.02, 95% CI 0.61 to 1.70; 1 study, 580 participants; very low-certainty evidence); cefazolin plus daptomycin versus cefazolin plus vancomycin (RR 1.44, 95% CI 0.58 to 3.54; 1 study, 178 participants; low-certainty evidence); teicoplanin versus cephradine (RR 0.68, 95% CI 0.17 to 2.72; 1 study, 134 participants; very low-certainty evidence); cloxacillin plus gentamicin versus cefotaxime (only in the long term) (RR 1.19, 95% CI 0.33 to 4.23; 1 study, 36 participants; very low-certainty evidence). For amputation rate, there was little or no difference between the second- or third-generation cephalosporin versus first-generation cephalosporin antibiotic classes (RR 3.14, 95% CI 0.33 to 30.13; 2 studies, 1269 participants; very low-certainty evidence). Closed incision negative pressure therapy versus standard wound drainage (nine studies) For graft infection rate, data from five studies showed little or no difference between the groups (RR 0.55, 95% CI 0.19 to 1.59; 5 studies, 802 participants; very low-certainty evidence). Data from nine studies may show a reduction in SSI rate (RR 0.49, 95% CI 0.27 to 0.86; 5 studies, 772 groin access; very low-certainty evidence) in the short and long term. For all-cause mortality (RR 1.78, 95% CI 0.22 to 14.32; 2 studies, 363 participants; very low-certainty evidence), re-intervention rate (RR 0.46, 95% CI 0.20 to 1.04; 3 studies, 436 participants; very low-certainty evidence), amputation (RR 0.34, 95% CI 0.01 to 8.38; 1 study, 234 participants; low-certainty evidence), and pain outcome (MD -0.10, 95% CI -0.25 to 0.05; 1 study, 242 participants; low-certainty evidence) there was little or no difference between the groups.

Authors' conclusions: Prophylactic antibiotics may reduce SSIs in peripheral arterial reconstruction of the lower limb with low-certainty evidence. We found no superiority among specific antibiotics or differences in extended use (over 24 hours) compared with shorter use (up to 24 hours), with low-certainty evidence. Closed incision negative pressure therapy may lower the SSI risk, but this is based on very low-certainty evidence. For other interventions, very low- to moderate-certainty evidence showed little or no significant differences across various outcomes. We advise caution when interpreting these conclusions due to the limited number of events in all groups and comparisons.

Trial registration: ClinicalTrials.gov NCT02389023 NCT02395159 NCT01913132 NCT02581904 NCT02084017 NCT01113892 NCT01229358 NCT01612052 NCT00873704 NCT02836990 NCT03308253 NCT03460262 NCT03468621 NCT03746132 NCT03935659 NCT04174183 NCT04453319 NCT04840576 NCT05434182.

PubMed Disclaimer

Conflict of interest statement

RMC: none known.

MABC: no relevant interests; vascular surgeon at Mater Dei Hospital.

LCUN: none known.

VV: Boston Scientific Ltd. (speaker arrangements); Centro Medico Alliance (private practice); Doctor at Federal University of São Paulo, Brazil.

RLGF: no relevant interests; Professor of Vascular Surgery at Universidade Federal de São Paulo, Brazil.

Update of

References

References to studies included in this review

Bertges 2020 {published data only}
    1. Bertges D, Smith L, Scully R, Wyers M, Eldrup-Jorgenson J, Suckow B et al. A multicenter, prospective randomized trial of negative pressure wound therapy for infrainguinal revascularization groin incisions. Journal of Vascular Surgery 2020;72(3):257-67. [DOI: 10.1016/j.jvs.2020.12.100] - DOI
Borrero 1991 {published data only}
    1. Borrero E, Rosenthal D. Comparison of cefuroxime and cefazolin: prophylaxis against infection in arterial reconstructive surgery. Vascular Surgery 1991;25(1):54-9. [DOI: 10.1177/153857449102500109] - DOI
Braithwaite 1998 {published data only}
    1. Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. British Journal of Surgery 1998;85(10):1378-81.
    1. Earnshaw JJ, Whitman B, Heather BP. Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic dacron grafts. British Journal of Surgery 2000;87(6):758-9. [DOI: 10.1046/j.1365-2168.2000.01490.x] - DOI
Chester 1983 {published data only}
    1. Chester JF, Fergusson CM, Chant AD. The effect of cephradine prophylaxis on wound infection after arterial surgery through a groin incision. Annals of the Royal College of Surgeons of England 1983;65(6):389-90. [PMID: ] - PMC - PubMed
Dunlop 1990 {published data only}
    1. Dunlop MG, Fox JN, Stonebridge PA, Clason AE, Ruckley CV. Vacuum drainage of groin wounds after vascular surgery: a controlled trial. British Journal of Surgery 1990;77(5):562-3. [DOI: 10.1002/bjs.1800770532] - DOI
Earnshaw 1988 {published data only}
    1. Earnshaw JJ, Slack RC, Makin GS, Hopkinson BR. Risk factors in vascular surgical sepsis. Annals of the Royal College of Surgeons of England 1988;70:139-43. [PMID: ] - PubMed
Earnshaw 1989 {published data only}
    1. Earnshaw JJ, Berridge DC, Slack RC, Makin GS, Hopkinson BR. Do preoperative chlorhexidine baths reduce the risk of infection after vascular reconstruction? European Journal of Vascular Surgery 1989;3(4):323-6. [DOI: 10.1016/s0950-821x(89)80068-4] - DOI
Edwards 1992 {published data only}
    1. Edwards WHJr, Kaiser AB, Kernodle DS, Appleby TC, Edwards WH Sr, Martin RS, et al. Cefuroxime versus cefazolin as prophylaxis in vascular surgery. Journal of Vascular Surgery 1992;15(1):35-41. [DOI: 10.1067/mva.1992.33841] - DOI
Edwards 1993 {published data only}
    1. Edwards WHJr, Kaiser AB, Tapper SS, Edwards WHSr, Martin RS, Mulherin JL et al. Cefamandole and cefazolin in vascular surgical wound prophylaxis: Cost versus efficacy. Journal of vascular surgery 1993;17(1):241-242. [DOI: 10.1067/mva.1993.48123] - DOI
Engelhardt 2018 {published data only}
    1. Engelhardt M, Rashad NA, Willy C, Muller C, Bauer C, Debus S, et al. Closed-incision negative pressure therapy to reduce groin wound infections in vascular surgery: a randomised controlled trial. International Wound Journal 2018;15(3):327-32. [DOI: 10.1111/iwj.12848] - DOI
Gombert 2018 {published data only}
    1. Gombert A, Babilon M, Barbati ME, Keszei A, Trotha KT, Jalaie H et al. Closed incision negative pressure therapy reduces surgical site infections in vascular surgery: a prospective randomised trial (AIMS trial). European Journal of Vascular & Endovascular Surgery 2018;56(3):442-8. [DOI: 10.1016/j.ejvs.2018.05.018] - DOI
Hasselgren 1984 {published data only}
    1. Hasselgren PO, Ivarsson L, Risberg B, Seeman T. Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Annals of Surgery 1984;200(1):86-92. [DOI: 10.1097/00000658-198407000-00016] - DOI
Hasselmann 2019 {published data only}
    1. Hasselmann J, Bjork J, Svensson-Bjork R, Acosta S. Inguinal vascular surgical wound protection by incisional negative pressure wound therapy: a randomized controlled trial - INVIPS Trial. Annals of Surgery 2015;271(1):562-71. [DOI: 10.4236/ss.2015.612080] - DOI
    1. Rezk F, Astrand H, Acosta S. Incisional negative pressure wound therapy for the prevention of surgical site infection after open lower limb revascularization - Rationale and design of a multi-center randomized controlled trial. Contemporary Clinical Trials Communications 2019;16:(no pagination). [DOI: 10.1016/j.conctc.2019.100469] - DOI
Jensen 1985 {published data only}
    1. Jensen LJ, Aagaard MT, Schifter S. Prophylactic vancomycin versus placebo in arterial prosthetic reconstructions. Thoracic & Cardiovascular Surgeon 1985;33(5):300-3. [DOI: 10.1055/s-2007-1014145] - DOI
Kaiser 1978 {published data only}
    1. Kaiser AB, Clayson KR, Mulherin JLJr, Roach AC, Allen TR, Edwards WH, et al. Antibiotic prophylaxis in vascular surgery. Annals of Surgery 1978;188(3):283-9. [DOI: 10.1097/00000658-197809000-00003] - DOI
Kester 1999 {published data only}
    1. Kester RC, Antrum R, Thornton CA, Ramsden CH, Harding I. A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. Journal of Hospital Infection 1999;41(3):233-43. [DOI: 10.1016/s0195-6701(99)90022-1] - DOI
Kwon 2018 {published data only}
    1. Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, et al. A randomized study evaluating negative-pressure therapy to decrease vascular groin wound complications. Journal of Vascular Surgery 2017;68(6):1744-52. [DOI: 10.1016/j.jvs.2018.05.224] - DOI
Lawlor 2011 {published data only}
    1. Lawlor DK, Derose G, Harris KA, Lovell MB, Novick TV, Forbes TL. The role of platelet-rich plasma in inguinal wound healing in vascular surgery patients. Vascular & Endovascular Surgery 2011;45(3):241-5. [DOI: 10.1177/1538574411399157] - DOI
Lee 2017 {published data only}
    1. Lee K, Murphy P, Ingves MV, Dubois L, Duncan A, Derose G, et al. Randomized controlled trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization. Journal of Vascular Surgery 2017;64:1814-9. [DOI: 10.1016/j.jvs.2017.06.084] - DOI
Lumsden 2015 {published data only}
    1. Lumsden AB, Morrissey NJ. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Journal of Vascular Surgery 2015;61(3):703-12. [DOI: 10.1016/j.jvs.2014.10.008] - DOI
Murphy 1995 {published data only}
    1. Murphy PG, Tadros E, Cross S, Hehir D, Burke PE, Kent P, et al. Skin closure and the incidence of groin wound infection: a prospective study. Annals of Vascular Surgery 1995;9(5):480-2. [DOI: 10.1007/BF02143863] - DOI
Ozaki 2015 {published data only}
    1. Ozaki CK, Hamdan AD, Barshes NR, Wyers M, Hevelone ND, Belkin M, et al. Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications. Journal of Vascular Surgery 2015;61(2):419-27. [DOI: 10.1016/j.jvs.2014.07.034] - DOI
Pitt 1980 {published data only}
    1. Pitt HA, Postier RG, MacGowan AW, Frank LW, Surmak AJ, Sitzman JV, et al. Prophylactic antibiotics in vascular surgery. Topical, systemic, or both? Annals of Surgery 1980;192(3):356-64. [DOI: 10.1097/00000658-198009000-00011] - DOI
Pleger 2018 {published data only}
    1. Pleger SP, Nink N, Elzien M, Kunold A, Koshty A, Boning A. Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study. International Wound Journal 2018;15(1):75-83. [DOI: 10.1111/iwj.12836] - DOI
Risberg 1995 {published data only}
    1. Risberg B, Drott C, Dalman P, Holm J, Ivarsson L, Jivegard L et al. Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study. European Journal of Vascular & Endovascular Surgery 1995;10(3):346-51. [DOI: 10.1016/s1078-5884(05)80055-3] - DOI
Robbs 1988 {published data only}
    1. Robbs JV, Reddy E, Ray R. Antibiotic prophylaxis in aortic and peripheral arterial surgery in the presence of infected extremity lesions. Results of a prospective evaluation. Drugs 1988;35:141-50. [DOI: 10.2165/00003495-198800352-00030] - DOI
Ross 1997 {published data only}
    1. Ross CB, Wheeler WG2nd, Jones MJ, Kerins CA, Peek TE. Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial. Southern Medical Journal 1997;90(1):16-22. [DOI: 10.1097/00007611-199701000-00004] - DOI
Salzmann 1982 {published data only}
    1. Salzmann G. Perioperative antibiotic prophylaxis in vascular surgery - a randomized prospective study. Thoracic and Cardiovascular Surgeon 1982;30:239-42. [DOI: 10.1055/s-2007-1021987] - DOI
Stone 2015 {published data only}
    1. Stone PA, AbuRahma AF, Campbell JR, Hass SM, Mousa AY, Nanjundappa A, et al. Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization. Annals of Surgery 2015;262(3):495-501. [DOI: 10.1097/SLA.0000000000001433] - DOI
Swinnen 2010 {published data only}
    1. Swinnen J, Chao A, Tiwari A, Crozier J, Vicaretti M, Fletcher J. Vertical or transverse incisions for access to the femoral artery: a randomized control study. Annals of Vascular Surgery 2010;24(3):336-41. [DOI: 10.1016/j.avsg.2009.07.020] - DOI
Turtiainen 2011 {published data only}
    1. Turtiainen J, Saimanen EI, Partio TJ, Makinen KT, Reinikainen MT, Virkkunen JJ, et al. Supplemental postoperative oxygen in the prevention of surgical wound infection after lower limb vascular surgery: a randomized controlled trial. World Journal of Surgery 2011;35(6):1387-95. [DOI: 10.1007/s00268-011-1090-y] - DOI
Turtiainen 2012 {published data only}
    1. Turtiainen J, Saimanen EI, Makinen KT, Nykanen AI, Venermo MA, Uurto IT et al. Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World Journal of Surgery 2012;36(10):2528-34. [DOI: 10.1007/s00268-012-1655-4] - DOI
Van Dijk 1995 {published data only}
    1. Dijk LC, Urk H, du Bois, NAJJ, Yo TI, Koning J, Jansen WBJ, et al. A new "closed" in situ vein bypass technique results in a reduced wound complication rate. European Journal of Vascular and Endovascular Surgery 1995;10(2):162-7. [DOI: 10.1016/S1078-5884(05)80107-8] - DOI
Vierhout 2014 {published data only}
    1. Vierhout BP, Ott A, Reijnen MM, Oskam J, Ott A, den Dungen JJ, et al. Cyanoacrylate skin microsealant for preventing surgical site infection after vascular surgery: a discontinued randomized clinical trial. Surgical Infections 2014;15(4):425-30. [DOI: 10.1089/sur.2013.191] - DOI
Walker 1984 {published data only}
    1. Walker M, Litherland MW, Murphy J, Smith J. Comparison of prophylactic antibiotic regimens inpatients undergoing vascular surgery. Journal of Hospital Infection 1984;5:101-6. [DOI: 10.1016/0195-6701(84)90039-2] - DOI
Wolterbeek 2002 {published data only}
    1. Wolterbeek JH, Leeuwen AA, Breslau PJ. Skin closure after infrainguinal bypass surgery: a prospective randomised study. European Journal of Vascular and Endovascular Surgery 2002;23(4):321-4. [DOI: 10.1053/ejvs.2001.1593] - DOI
Worning 1986 {published data only}
    1. Worning AM, Frimodt-Moller N, Ostri P, Nilsson T, Hojholdt K, Frimodt-Moller C. Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled study. Journal of Antimicrobial Chemotherapy 1986;17(1):105-13. [DOI: 10.1093/jac/17.1.105] - DOI
Wubbeke 2020 {published data only}
    1. Wubbeke LF, Telgenkamp B, Boxtel T, Bolt LJJ, Houthoofd S, Vriens PWHE, et al. Gentamicin containing collagen implants and groin wound infections in vascular surgery: a prospective randomised controlled multicentre trial. European Journal of Vascular & Endovascular Surgery 2020;59(4):635-41. [DOI: 10.1016/j.ejvs.2020.01.010] - DOI
Youssef 2005 {published data only}
    1. Youssef F, Jenkins MP, Dawson KJ, Berger L, Myint F, Hamilton G. The value of suction wound drain after carotid and femoral artery surgery: a randomised trial using duplex assessment of the volume of post-operative haematoma. European Journal of Vascular & Endovascular Surgery 2005;29(2):162-6. [DOI: 10.1016/j.ejvs.2004.09.026] - DOI
Zdanowski 2000 {published data only}
    1. Zdanowski Z, Danielsson G, Jonung T, Norgren L, Ribbe E, Thorne J, et al. Intraoperative contamination of synthetic vascular grafts. Effect of glove change before graft implantation. A prospective randomised study. European Journal of Vascular & Endovascular Surgery 2000;19(3):283-7. [DOI: 10.1053/ejvs.1999.1035] - DOI

References to studies excluded from this review

Barlow 1989 {published data only}
    1. Barlow IW, Ausobsky JR, Wilkinson D, Kester RC. Controlled trial of cephradine versus cefuroxime in vascular surgery. International Journal of Clinical Pharmacology Research 1989;9(3):223-7. [PMID: ] - PubMed
Branchereau 1987 {published data only}
    1. Branchereau A, Ondo N'Dong F, La Selve L. Antibioprevention in reconstructive arterial surgery. A double-blind study. Presse Medicale 1987;16(33):1633-5. [PMID: ] - PubMed
Christenson 1981 {published data only}
    1. Christenson JT, Eklof B, Hedstrom SA, Kamme C. Prevention of synthetic arterial graft infections by improved hygienic routine and dicloxacillin administration. Scandinavian Journal of Infectious Diseases 1981;13(1):51-7. [DOI: 10.1080/00365548.1981.11690367] - DOI
D'Addato 1996 {published data only}
    1. D'Addato M, Curti T, Freyrie A. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Cardiovascular Surgery 1996;4(2):200-4. [DOI: 10.1016/0967-2109(96)82315-5] - DOI
Dieterich 1989 {published data only}
    1. Dieterich HJ, Behringer K, Lauterjung L, Peter K. Prophylactic activity of amoxicillin/clavulanic acid and cefoxitin in vascular surgery--a randomized clinical study. Journal of Chemotherapy (Florence, Italy) 1989;1(4 Suppl):1059.
Hall 1998 {published data only}
    1. Hall JC, Christiansen KJ, Goodman M, Lawrence-Brown M, Prendergast FJ, Rosenberg P, et al. Duration of antimicrobial prophylaxis in vascular surgery. American Journal of Surgery 1998;175(2):87-90. [DOI: 10.1016/S0002-9610(97)00270-5] - DOI
Harnoss 1996 {published data only}
    1. Harnoss BM, Gerking N, Bose-Landgraf J, Hopfenmuller W. Perioperative antibiotic prophylaxis in reconstructive vascular surgery. [German]. Klinikarzt 1996;25(4):137-42.
Healy 1989 {published data only}
    1. Healy DA, Keyser III J, Holcomb III GW, Dean RH, Smith BM. Prophylactic closed suction drainage of femoral wounds in patients undergoing vascular reconstruction. Journal of Vascular Surgery 1989;10(2):166-8. [PMID: ] - PubMed
Kitzis 1986 {published data only}
    1. Kitzis M, Picard B, Chalaux G, Andreassian B. Value of short prophylactic antibiotherapy in thoracic and vascular surgery. Comparative randomized double-blind study of 3 and 8 injections of cefamandole. Journal de Chirurgie 1986;123(12):709-12. [PMID: ] - PubMed
Maki 1992 {published data only}
    1. Maki DG, Bohn MJ, Stolz SM, Kroncke GM, Acher CW, Myerowitz PD. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. Journal of Thoracic & Cardiovascular Surgery 1992;104(5):1423-34. [PMID: ] - PubMed
Marroni 1999 {published data only}
    1. Marroni M, Cao P, Fiorio M, Maghini M, Lenti M, Repetto A, et al. Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery. European Journal of Clinical Microbiology & Infectious Diseases 1999;18(3):175-8. [DOI: 10.1007/s100960050253] - DOI
May 1980 {published data only}
    1. May AR, Darling RC, Brewster DC, Darling CS. A comparison of the use of cephalothin and oxacillin in vascular surgery. Archives of Surgery 1980;115(1):56-9. [DOI: 10.1001/archsurg.1980.01380010048009] - DOI
Miani 1982 {published data only}
    1. Miani S, Scorza R, Piglionica R. Intraoperative antibiotic perfusion. Control parameters. Archivio Per Le Scienze Mediche 1982;139(4):429-34. [PMID: ] - PubMed
Moreira 1989 {published data only}
    1. Moreira RCR, Ribas TJR, Goes JrDCA, Silva AB, Elias A. Prevenindo infecçäo em cirurgia arterial: resultados de um programa de profilaxia em 1.012 casos. Revista do Colégio Brasileiro de Cirurgiões 1989;16(2):75-9.
Muckenhuber 1985 {published data only}
    1. Muckenhuber P, Salem G. Prospective randomized study: cefuroxime and netilmicin versus ceftriaxone as prophylaxis in vascular surgery. Wiener Medizinische Wochenschrift - Supplement 1985;87:27-8. [PMID: ] - PubMed
Noto 2015 {published data only}
    1. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 2015;313(4):369-78. [DOI: 10.1001/jama.2014.18400] - DOI
Patrick 2010 {published data only}
    1. Patrick S, James C, Ali A, Lawson S, Mary E, Modak A. Vascular surgical antibiotic prophylaxis study (VSAPS). Vascular & Endovascular Surgery 2010;44(7):521-8. [DOI: 10.1177/1538574410373837] - DOI
Patrick 2011 {published data only}
    1. NCT01612052. Vascular surgical antibiotic prophylaxis study (VSAPS 2). NCT01612052 2011. [NCT: 01612052]
Pratesi 2001 {published data only}
    1. Pratesi C, Russo D, Dorigo W, Chiti E. Antibiotic prophylaxis in clean surgery: vascular surgery. Journal of Chemotherapy 2001;13(1):123-8. [DOI: 10.1179/joc.2001.13.Supplement-2.123] - DOI
Raschke 1994 {published data only}
    1. Raschke R, Muhe M, Husfeldt KJ, Neumeier R. Perioperative antibiotic prophylaxis in vascular surgery. Study on tissue and serum levels in femoropopliteal surgery. [German]. Zentralblatt fur Chirurgie 1994;119(1):103-6.
Recker 1987 {published data only}
    1. Recker F, Geroulanos S, Turina M. Perioperative antibiotic prophylaxis in heart and vascular surgery. A prospective randomized comparative study with cefazolin and ceftriaxone [German]. Deutsche Medizinische Wochenschrift 1987;112(4):135-8.
Sabat 2016 {published data only}
    1. Sabat J, Tyagi S, Srouji A, Pechman D, Gupta AM, Lucido D et al. Prophylactic negative-pressure therapy for femoral incision in vascular surgery: preliminary results of a prospective, randomized trial. Journal of Vascular Surgery 2016;63:94S-95S. [DOI: 10.1016/j.jvs.2016.03.099] - DOI
Schmitt 1990 {published data only}
    1. Schmitt D. Antibiotic usage in the prevention and treatment of graft infection. Seminars in Vascular Surgery 1990;3(2):133-40.
Schwartz 2014 {published data only}
    1. Schwartz J, Goss S, Facchin F, Manizate F, Gendics C, Braitman E, et al. A prospective two-armed trial assessing the efficacy and performance of a silver dressing used postoperatively on high-risk, clean surgical wounds. Ostomy Wound Management 2014;60(4):30-40. [PMID: ] - PubMed
Stone 2009 {published data only}
    1. Stone PA, AbuRahma AF. Vascular surgical antibiotic prophylactic study (VSAPS). Journal of Vascular Surgery 2009;50(6):1533. [DOI: 10.1016/j.jvs.2009.10.009] - DOI
Svensson‐Bjork 2018 {published data only}
    1. Svensson-Bjork R, Hasselmann J, Acosta S. Evaluation of inguinal vascular surgical scars treated with closed incisional negative pressure wound therapy using three-dimensional digital imaging- a randomized controlled trial on bilateral incisions. Wound Repair & Regeneration 2018;26(1):77-86. [DOI: 10.1111/wrr.12615] - DOI
Totty 2019 {published data only}
    1. Totty JP, Hitchman LH, Cai PL, Harwood AE, Wallace T, Carradice D, et al. A pilot feasibility randomised clinical trial comparing dialkylcarbamoylchloride-coated dressings versus standard care for the primary prevention of surgical site infection. International Wound Journal 2019;16(4):883-90. [DOI: 10.1111/iwj.13113] - DOI
Veit 1986 {published data only}
    1. Veit R, Melliere D, Etienne G, Becquemin JP, Brunbuisson C, Otterbein G. Which antibiotics should one choose for prophylaxis in vascular surgery? [French]. Journal de Chirurgie 1986;123(11):621-5. [PMID: ] - PubMed
Weber 2017 {published data only}
    1. Mujagic E, Zwimpfer T, Marti WR, Zwahlen M, Hoffmann H, Kindler C, et al. Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial. Trials 2014;15(1):188-97. [DOI: 10.1186/1745-6215-15-188] - DOI
    1. Weber WW, Mujagic E, Zwahlen M, Bundi M, Hoffmann H, Soysal SD, et al. Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial. Lancet 2017;17(6):605-14. [DOI: 10.1016/S1473-3099(17)30176-7] - DOI

References to ongoing studies

NCT02836990 {published data only}
    1. NCT02836990. Prevena vs dermabond in groin wound infections in vascular surgery. https://clinicaltrials.gov/study/NCT02836990 2016. [NCT: 02836990]
NCT02992951 {published data only}
    1. NCT02992951. DACC in the reduction of surgical site infection. https://clinicaltrials.gov/show/NCT02992951 2016. [NCT: 02992951]
NCT03308253 {published data only}
    1. NCT03308253. Study for antibiotic impregnated calcium sulfate beads as prophylaxis for surgical site infection. https://clinicaltrials.gov/study/NCT03308253 2018. [NCT: 03308253]
NCT03460262 {published data only}
    1. Negative pressure wound therapy for prevention of groin infection following vascular surgery. NCT03460262 2018. [NCT: 03460262]
NCT03468621 {published data only}
    1. Hakovirta H. Relation of skin closure method to groin wound infections after proximal femoral artery exposure. https://clinicaltrials.gov/show/NCT03468621 2018. [NCT: 03468621]
NCT03746132 {published data only}
    1. A prospective, randomized, crossover study of transdermal, continuous oxygen therapy for surgical site wound healing in high-risk subjects undergoing lower extremity revascularization. NCT03746132. [NCT: 03746132]
NCT03935659 {published data only}
    1. NCT03935659. Negative pressure wound therapy for surgical site infection prevention in common femoral artery exposure. https://clinicaltrials.gov/study/NCT03935659 2018. [NCT: 03935659]
NCT04174183 {published data only}
    1. NCT04174183. Evaluation of the effectiveness of a closed-incision negative-pressure therapy (Prevena®) on bilateral groin incision. https://clinicaltrials.gov/show/NCT04174183 2019. [NCT: 04174183]
NCT04238923 {published data only}
    1. NCT04238923. Topical gentamicin and vancomycin for vascular surgical site infection prophylaxis. https://clinicaltrials.gov/study/NCT04238923 2020. [NCT: 04238923]
NCT04453319 {published data only}
    1. NCT04453319. Efficacy of negative pressure wound closure therapy by PICO system in prevention of complications of femoral artery exposure. https://clinicaltrials.gov/show/NCT04453319 2020. [NCT: 04453319]
NCT04840576 {published data only}
    1. NCT04840576. Prophylactic negative wound pressure therapy (PICO-7) following groin incisions in vascular surgery (PICO-Vasc Study). https://clinicaltrials.gov/show/NCT04840576 2021. [NCT: 04840576]
NCT05434182 {published data only}
    1. Intradermal suture versus stapling for groin skin closure in vascular surgery (VASC-INF Trial). NCT05434182. [NCT: 05434182]
NTR6481 {published data only}
    1. Lenselink E. RCT incisional NPWT versus sterile surgical dressing for surgical wounds after arterial vascular surgery. https://trialsearch.who.int/Trial2.aspx?TrialID=NTR6481 2017. [NTR: 6481]

Additional references

Aboyans 2018
    1. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, et al. Guidelines on the diagnosis and treatment of peripheral arterial diseases. European Journal of Vascular and Endovascular Surgery 2018;55(3):305-68. [PMID: ] - PubMed
Allegranzi 2016a
    1. Allegranzi B, Bischoff P, Jonge S, Kubilay NZ, Zayed B, Gomes SM, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infection Diseases 2016;16(12):e276-87. [DOI: 10.1016/S1473-3099(16)30398-X] - DOI
Allegranzi 2016b
    1. Allegranzi B, Zayed B, Bischoff P, Kubilay NZ, Jonge S, Vries F, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infectious Diseases 2016;16(12):e288-303. [DOI: 10.1016/S1473-3099(16)30402-9] - DOI
Andercou 2018
    1. Andercou O, Marian D, Olteanu G, Stancu B, Cucuruz B, Noppeney T. Complex treatment of vascular prostheses infections. Medicine 2018;97(27):e11350. [DOI: 10.1097/MD.0000000000011350] - DOI
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490-4. [DOI: 10.1136/bmj.328.7454.1490] - DOI
Bailey 1992
    1. Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after hernia surgery. BMJ 1992;304:469-71. [DOI: 10.1136/bmj.304.6825.469.] - DOI
Bandyk 2008
    1. Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Seminars in Vascular Surgery 2008;21(3):119-23. [DOI: 10.1053/j.semvascsurg.2008.05.008] - DOI
Benson 2021
    1. Benson RA, Nandhra S. Outcomes of vascular and endovascular interventions performed during the coronavirus disease 2019 (COVID-19) pandemic. Annals of Surgery 2021;273(4):630-5. [PMID: ] - PMC - PubMed
Berríos‐Torres 2017
    1. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery 2017;152(8):784-91. [DOI: 10.1001/jamasurg.2017.0904] - DOI
Bradbury 2023
    1. Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023;401:1798-809. [DOI: 10.1016/S0140-6736(23)00462-2] - DOI
Bratzler 2013
    1. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health-System Pharmacy Surgical Infections;2013(14):73-156. [DOI: 10.1089/sur.2013.9999] - DOI
Chakfé 2020
    1. Chakfé N, Diener H, Lejay A, Assadian O, Berard X, Caillon J, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections. European Journal of Vascular and Endovascular Surgery 2020;59(3):339-84. [PMID: ] - PubMed
Cheng 2017
    1. Cheng H, Chen BP, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged operative duration increases risk of surgical site infections: a systematic review. Surgical Infections 2017;18(6):722-35. [PMID: ] - PMC - PubMed
Conte 2010
    1. Conte MS. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. Journal of Vascular Surgery 2010;51(5 Suppl):69S-75S. [DOI: 10.1016/j.jvs.2010.02.001] - DOI
Conte 2019
    1. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. European Journal of Vascular and Endovascular Surgery 2019;58(1S):S1-S109.e33. [DOI: 10.1016/j.ejvs.2019.05.006] - DOI
Covidence [Computer program]
    1. Covidence. Version accessed January 2023. Melbourne, Australia: Veritas Health Innovation, 2023. Available at https://www.covidence.org.
COVIDSurg 2021
    1. COVIDSurg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 2021;76(6):748-58. [DOI: 10.1111/anae.15458] - DOI
Cristino 2025
    1. Cristino MA, Nakano LC, Vasconcelos V, Correia RM, Flumignan RL. Prevention of infection in aortic or aortoiliac peripheral arterial reconstruction. Cochrane Database of Systematic Reviews 2025, Issue 4. Art. No: CD015192. [DOI: 10.1002/14651858.CD015192.pub2] - DOI
Cruccu 2004
    1. Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpää M, Jørum E, et al. EFNS guidelines on neuropathic pain assessment. European Journal of Neurology 2004;11(3):153-62. [DOI: 10.1111/j.1468-1331.2004.00791.x] - DOI
Davis 2017
    1. Davis FM, Sutzko DC, Grey SF, Mansour MA, Jain KM, Nypaver TJ, et al. Predictors of surgical site infection after open lower extremity revascularization. Journal of Vascular Surgery 2017;65(6):1769-78. [DOI: 10.1016/j.jvs.2016.11.053] - DOI
Deeks 2021
    1. Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook/archive/v6.2.
Dumville 2016
    1. Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T, Macefield R, et al. Dressings for the prevention of surgical site infection. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No: CD003091. [DOI: 10.1002/14651858.CD003091.pub4] - DOI
ECDC 2013
    1. European Centre for Disease Prevention and Control. Systematic review and evidence-based guidance on perioperative antibiotic prophylaxis. www.ecdc.europa.eu 2013. [DOI: 10.2900/85936] - DOI
Eiberg 2006
    1. Eiberg JP, Røder O, Stahl-Madsen M, Eldrup N, Qvarfordt P, Laursen A, et al. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial. European Journal of Vascular and Endovascular Surgery 2006;32(4):431-8. [DOI: 10.1016/j.ejvs.2006.04.018] [PMID: ] - DOI - PubMed
Exton 2007
    1. Exton RJ, Galland RB. Major groin complications following the use of synthetic grafts. European Journal of Vascular and Endovascular Surgery 2007;34(2):188-90. [PMID: ] - PubMed
Farber 2022
    1. Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. New England Journal of Medicine 2022;387:2305-16. [DOI: 10.1056/NEJMoa2207899] - DOI
Flumignan 2018
    1. Flumignan CD, Amaral FC, Flumignan RL, Vasconcelos VT, Attie GA, Daolio RM, et al. Angioplasty and stenting for below the knee ulcers in diabetic patients: protocol for a systematic review. Systematic Reviews 2018;7(1):228. [PMID: ] - PMC - PubMed
Fowkes 2013
    1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382(9901):1329-40. [DOI: 10.1016/S0140-6736(13)61249-0] - DOI
Fowkes 2017
    1. Fowkes FG, Aboyans V, Fowkes FJ, McDermott MM, Sampson UK, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nature Reviews. Cardiology 2017;14(3):156-70. [PMID: ] - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed January 2023. Hamilton (ON): McMaster University (developed by Evidence Prime), 2023. Available at https://www.gradepro.org.
Greenblatt 2010
    1. Greenblatt DY, Rajamanickam V, Mell MW. Predictors of surgical site infection after open lower extremity revascularization. Journal of Vascular Surgery 2011;54(2):433-9. [DOI: 10.1016/j.jvs.2011.01.034] - DOI
Hamouda 2015
    1. Hamouda K, Oezkur M, Sinha B, Hain J, Menkel H, Leistner M, et al. Different duration strategies of perioperative antibiotic prophylaxis in adult patients undergoing cardiac surgery: an observational study. Journal of Cardiothoracic Surgery 2015;10:25. [PMID: ] - PMC - PubMed
Hekman 2019
    1. Hekman KE, Michel E, Blay E Jr, Helenowski IB, Hoel AW. Evidence-based bundled quality improvement intervention for reducing surgical site infection in lower extremity vascular bypass procedures. Journal of the American College of Surgeons 2019;228(1):44-53. [DOI: 10.1016/j.jamcollsurg.2018.10.002] - DOI
Herten 2017
    1. Herten M, Idelevich EA, Sielker S, Becker K, Scherzinger AS, Osada N, et al. Vascular graft impregnation with antibiotics: the influence of high concentrations of rifampin, vancomycin, daptomycin and bacteriophage endolysin HY-133 on viability of vascular cells. Medical Science Monitor Basic Research 2017;23:250-7. [PMID: ] - PMC - PubMed
Hicks 1997
    1. Hicks RC, Greenhalgh RM. The pathogenesis of vascular graft infection. European Journal of Vascular and Endovascular Surgery 1997;14:5-9. [DOI: 10.1016/s1078-5884(97)80143-8] - DOI
Higgins 2017
    1. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2. The Cochrane Collaboration, 2017. Available from https://www.cochrane.org/authors/handbooks-and-manuals/handbook/archive/....
Higgins 2021
    1. Higgins JP, Eldridge S, Li T. Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Homer‐Vanniasinkam 2007
    1. Homer-Vanniasinkam S. Surgical site and vascular infections: treatment and prophylaxis. International Journal of Infectious Diseases 2007;11(S1):S17-22. [DOI: 10.1016/S1201-9712(07)60003-4] - DOI
Horan 1992
    1. Horan T, Gaynes RP, Martone W, Jarvis W, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. American Journal of Infection Control 1992;20(5):271-4. [DOI: 10.1016/S0196-6553(05)80201-9] - DOI
Kirkham 2023
    1. Kirkham AM, Candeliere J, McIsaac DI, Stelfox HT, Dubois L, Gill HL, et al. Efficacy of strategies intended to prevent surgical site infection after lower limb revascularization surgery. 2023 Annals of Surgery;278(3):e447-56. [DOI: 10.1097/SLA.0000000000005867] - DOI
Lefebvre 2022
    1. Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.
Legout 2011
    1. Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clinical Microbiology and Infection 2011;18:352-8. [DOI: 10.1111/j.1469-0691.2011.03618.x] - DOI
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine 2009;6(7):e1000100. [DOI: 10.1371/journal.pmed.1000100] - DOI
Lum 2016
    1. Kilic A, Arnaoutakis DJ, Reifsnyder T, Black JH 3rd, Abularrage CJ, Perler BA, et al. Management of infected vascular grafts. Vascular Medicine 2016;21(1):53-60. [DOI: 10.1177/1358863X15612574] - DOI
Lyons 2016
    1. Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the management of aortic graft infection collaboration (MAGIC). European Journal of Vascular and Endovascular Surgery 2016;52:758-63. [DOI: 10.1016/j.ejvs.2016.09.007] - DOI
Norman 2020
    1. Norman G, Goh EL, Dumville JC, Shi C, Liu Z, Chiverton L, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database of Systematic Reviews 2020, Issue 6. Art. No: CD009261. [DOI: 10.1002/14651858.CD009261.pub6] - DOI
Numan 2011
    1. Numan F, Gulsen F, Solak S, Cantasdemir M. Management of endograft infections. Journal of Cardiovascular Surgery 2011;52:205-23. [PMID: ] - PubMed
Ozan 2017
    1. Ozan F, Gürbüz K, Çelik Î, Dursun ZB, Uzun E. Evaluation of major and minor lower extremity amputation in diabetic foot patients. Turkish Journal of Medical Sciences 2017;47(4):1109-16. [PMID: ] - PubMed
O’Brien 2010
    1. O’Brien R, Pocock N, Torella F. Wound infection after reconstructive arterial surgery of the lower limbs: risk factors and consequences. Surgeon 2011;9(5):245-8. [DOI: 10.1016/j.surge.2010.10.005] - DOI
Pitt 1980
    1. Pitt HA, Postier RG, MacGowan AW, Frank LW, Surmak AJ, Sitzman JV, et al. Prophylactic antibiotics in vascular surgery. Topical, systemic, or both? Annals of Surgery 1980;192(3):356-64. [PMID: ] - PMC - PubMed
Pollock 1979
    1. Pollock AV. Surgical wound sepsis. Lancet 1979;313:1283-6. [DOI: 10.1016/s0140-6736(79)92239-6] - DOI
Radwan‐Pragłowska 2019
    1. Radwan-Pragłowska J, Piątkowski M, Deineka V, Janus Ł, Korniienko V, Husak E, et al. Chitosan-based bioactive hemostatic agents with antibacterial properties-synthesis and characterization. Molecules 2019;24(14):2629. [DOI: 10.3390/molecules24142629] - DOI
Review Manager 2020 [Computer program]
    1. Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.
RevMan 2022 [Computer program]
    1. Review Manager (RevMan). Version 4.3.0. The Cochrane Collaboration, 2022. Available at https://revman.cochrane.org.
Rezk 2019
    1. Rezk A, Åstrand H, Acosta S. Incisional negative pressure wound therapy for the prevention of surgical site infection after open lower limb revascularization – rationale and design of a multi-center randomized controlled trial. Contemporary Clinical Trials Communications 2019;14(16):100469. [DOI: 10.1016/j.conctc.2019.100469] - DOI
Sarpe 2023
    1. Sarpe AK, Flumignan CD, Nakano LC, Trevisani VF, Lopes RD, Guedes Neto HJ, et al. Duplex ultrasound for surveillance of lower limb revascularisation. Cochrane Database of Systematic Reviews 2023, Issue 7. Art. No: CD013852. [DOI: 10.1002/14651858.CD013852.pub2] - DOI
Schünemann 2021a
    1. Schünemann HJ, Vist GE, Higgins JP, Santesso N, Deeks JJ, Glasziou P, et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Schünemann 2021b
    1. Schünemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.
Septimus 2016
    1. Septimus EJ, Schweizer ML. Decolonization in prevention of health care-associated infections. Clinical Microbiology Reviews 2016;29(2):201-22. [PMID: ] - PMC - PubMed
SIGN 2014
    1. Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic prophylaxis in surgery. http://www.sign.ac.uk 2008;1:734-819. [ISBN: 978 1 905813 34 6]
Siracuse 2013
    1. Siracuse JJ, Nandivada P, Giles KA, Hamdan AD, Wyers MC, Chaikof EL, et al. Prosthetic graft infections involving the femoral artery. Journal Vascular Surgery 2013;57(3):700-5. [DOI: 10.1016/j.jvs.2012.09.049] - DOI
Sterne 2017
    1. Sterne JA, Egger M, Moher D, Boutron I, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.
Stewart 2006
    1. Stewart A, Eyers PS, Earnshaw JJ. Prevention of infection in arterial reconstruction. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD003073. [DOI: 10.1002/14651858.CD003073.pub2] - DOI
Stewart 2007
    1. Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. Journal of Vascular Surgery 2007;46(1):148-55. [DOI: 10.1016/j.jvs.2007.02.065] - DOI
Szilagyi 1972
    1. Szilagyi DE, Smith RE, Elliott JP, Vrandedii NP. Infection in arterial reconstruction with synthetic grafts. American Journal of Surgery 1972;176:321-33. [DOI: 10.1097/00000658-197209000-00008] - DOI
Wan 2014
    1. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology 2014;14:135. [PMID: ] - PMC - PubMed
Wengrovitz 1990
    1. Wengrovitz M, Atnip RG, Gifford RR, Neumyer MM, Heitjan DF, Thiele BL. Wound complications of autogenous subcutaneous infrainguinal arterial bypass surgery: predisposing factors and management. Journal of Vascular Surgery 1990;11:156-63. [DOI: 10.1016/0741-5214(90)90340-G] - DOI
Williamson 2017
    1. Williamson DA, Carter GP, Howden BP. Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns. Clinical Microbiology Reviews 2017;30(3):827-60. [PMID: ] - PMC - PubMed
Wilson 1986
    1. Wilson APR, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986;327:311-2. [DOI: 10.1016/s0140-6736(86)90838-x] - DOI

References to other published versions of this review

Correia 2022
    1. Correia RM, Nakano LC, Vasconcelos V, Flumignan RL. Prevention of infection in peripheral arterial reconstruction of the lower limb. Cochrane Database of Systematic Reviews 2022, Issue 9. Art. No: CD015022. [DOI: 10.1002/14651858.CD015022] - DOI

MeSH terms

Substances

Associated data

LinkOut - more resources